Exosens décroche un contrat majeur de 17 000 monoculaires de vision nocturne nouvelle génération avec l'armée espagnole

Exosens décroche un contrat majeur de 17 000 monoculaires de vision nocturne nouvelle génération avec l'armée espagnole EXOSENS DÉCROCHE UN CONTRAT MAJEUR DE 17 000 MONOCULAIRES DE VISION NOCTURNE NOUVELLE GÉNÉRATION AVEC L'ARMÉE ESPAGNOLE COMMUNIQUÉ DE PRESSEMÉRIGNAC, FRANCE – 29 SEPTEMBRE 2025 Exosens annonce la signature avec le ministère espagnol de la Défense d’un contrat d'approvisionnement portant sur 17 000 monoculaires de vision nocturne avec NVLS (Night Vision Lasers Spain), récemment racheté par Exosens, utilisant les tubes intensificateurs 4G 16 mm d'Exosens, qui seront livré...

Exosens secures major contract with the Spanish army for 17 000 advanced night vision monoculars

Exosens secures major contract with the Spanish army for 17 000 advanced night vision monoculars EXOSENS SECURES MAJOR CONTRACT WITH THE SPANISH ARMY FOR 17 000 ADVANCED NIGHT VISION MONOCULARS PRESS RELEASEMÉRIGNAC, FRANCE – SEPTEMBER, 29th 2025 Exosens announces that the Spanish Ministry of Defense, has signed a supply contract of 17 000 night vision monoculars to its recent acquisition NVLS, using Exosens’ 16 mm 4G intensifier tubes, to be delivered from 2025 to 2028.NVLS contributes to European sovereignty by reinforcing its industrial capacity as a key Spanish supplier for night vis...

Daimler Truck : Sustainability Weekly 8 - 12 September 2025

Last week, we published a report in which we propose ideas on the theme of sustainable sovereignty. Technip Energies signed an agreement to acquire the Advanced Materials & Catalysts business of Ecovyst Inc, a global leader in specialty catalysts and advanced materials. The IEA is expected to reintroduce its slow transition scenario, ‘Current Policies’, in its next World Energy Outlook, probably under pressure from the Trump administration. German Chancellor Merz has hinted at a slowdown in the pace of renewable energy development. Mercedes is the only European car manufacturer that may not me...

Lhyfe : Des objectifs revus en baisse dans un contexte sous contrainte

Gensight Biologics : Compassionate access launch still hoped for in Q4

Carnival : Good quality H1 results, a shade above forecasts